<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Family Reprod Health</journal-id><journal-id journal-id-type="iso-abbrev">J Family Reprod Health</journal-id><journal-id journal-id-type="publisher-id">JFRH</journal-id><journal-title-group><journal-title>Journal of Family &#x00026; Reproductive Health</journal-title></journal-title-group><issn pub-type="ppub">1735-8949</issn><issn pub-type="epub">1735-9392</issn><publisher><publisher-name>Tehran University of Medical Sciences</publisher-name><publisher-loc>Tehran, Iran</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26175764</article-id><article-id pub-id-type="pmc">4500821</article-id><article-id pub-id-type="publisher-id">JFRH-9-93</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Effect of Soy Milk Consumption on Quality of Life in Iranian Postmenopausal Women </article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nourozi</surname><given-names>Mansoreh</given-names></name><degrees>M.Sc.</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Haghollahi</surname><given-names>Fedyeh</given-names></name><degrees>M.Sc.</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ramezanzadeh</surname><given-names>Fatemeh</given-names></name><degrees>M.D.</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Hanachi</surname><given-names>Parichehr</given-names></name><degrees>Ph.D.</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Valie-Asr Reproductive Health Research Center, Tehran University of Medical Science, Tehran, Iran</aff><aff id="aff2"><label>2</label>Department of Biology, Biochemistry Unite, Faculty of Basic Sciences, Alzahra University, Tehran, Iran</aff><author-notes><corresp id="cor">Correspondence: Fedyeh Haghollahi, Vali-e-Asr Reproductive Health Research Center, Imam Hospital, Keshavarz Blvd., Tehran-14194, Iran<email>edyeh_hagh@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>6</month><year>2015</year></pub-date><volume>9</volume><issue>2</issue><fpage>93</fpage><lpage>100</lpage><history><date date-type="received"><month>6</month><year>2014</year></date><date date-type="rev-recd"><month>10</month><year>2014</year></date><date date-type="accepted"><month>10</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; Vali-e-Asr Reproductive Health Research Center, Tehran University of Medical Sciences</copyright-statement><license><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>
<bold>Objective:</bold> To find out whether or not soy milk as a phytoestrogen product can improve the quality of life of the Iranian postmenopausal women. </p><p>
<bold>Materials and methods:</bold> Participants of this randomized clinical trial were 57 healthy postmenopausal women. All eligible women were randomly divided into two groups of soy milk (SG) and control (CG). Individuals in the SG (n = 34) received 500 ml soy milk including genistein (28.86 mg/dl) and daidzein (8.25 mg/dl) per day, while the participants in the CG (n = 23) received 500 ml low fat cow milk per day during 8 months. Both groups also took daily calcium-D capsules (500 mg calcium and 200 IU D3). The quality of life of all participants was examined twice (at the baseline and the end of the eighth month) using the menopause-specific quality of life (MENQOL) questionnaire.</p><p>
<bold>Results:</bold> A total of 57 healthy postmenopausal women with a mean age of 52.13 (3.05) years were included in this study. Despite the significant but weak difference was observed between SG and CG in the sexual domain score (the mean of percent change: 0.46% vs. 33.94%, respectively; p = 0.031), while significant relationship was found between the soy milk consumption and improvement in the domains studied (vasomotor, psychosocial and physical).</p><p>
<bold>Conclusion:</bold> Overall our findings showed that soy milk does not improve the quality of life in postmenopausal women. But to achieve more reliable results, it is recommended further study to be done with a larger sample size, more prolonged, and with participants having severer vasomotor symptoms.</p></abstract><kwd-group><title>Key Words</title><kwd>Quality of Life</kwd><kwd>Post menopausal</kwd><kwd>Soy Milk</kwd><kwd>MENQOL</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>The most recent definition of quality of life presented by World Health Organization (WHO) (QOL) is &#x0201c;the individual&#x02019;s perception of their position in life in the context of culture and value systems in which they live and in relation to their goals, expectations, standards and concerns" (<xref rid="B1" ref-type="bibr">1</xref>).</p><p> Although menopause is not a disease, it is a natural event happening in middle-aged women. However, the cessation of ovarian activity and subsequent hormonal changes (especially in the absence of estrogen) lead to several problems that can affect the quality of life in postmenopausal women (<xref rid="B2" ref-type="bibr">2</xref>-<xref rid="B4" ref-type="bibr">4</xref>).</p><p>The problems experienced by postmenopausal women are of varying degrees (depending on the years after menopause, hormonal interventions, ethnicity, lifestyle, etc.) that generally include vasomotor instability (hot flashes, flushing, and sweating), sleep disturbance, depression, atrophic changes (atrophy in vaginal and vulvar epithelium, generalized atrophy of the skin, and urinary tract problems), osteoporosis and cardiovascular disease, and partly change in sexual desire (<xref rid="B5" ref-type="bibr">5</xref>).</p><p>Several studies have found that a sufficient dose of estrogen (hormone replacement therapy) is effective in mitigating the symptoms of menopause and improving the quality of life (<xref rid="B6" ref-type="bibr">6</xref>-<xref rid="B9" ref-type="bibr">9</xref>). However, in a study by Rossouw et al., 2002, they have cast doubt on the protective effects of hormone therapy in reducing the risk of coronary heart disease in postmenopausal women and confirmed the increased risk of stroke, invasive breast cancer, deep vein thrombosis and pulmonary embolism in consumers of hormone replacement (<xref rid="B10" ref-type="bibr">10</xref>). Therefore, researchers were encouraged to look for an alternative therapy that would not only be risk-free, but would also compensate for the estrogen deficiency.</p><p>Given the obvious differences in the incidence of hot flashes between postmenopausal women in Asia and their Western counterparts (10 to 25 percent of Chinese and Indonesian women and 58 to 93 percent of Western women) (<xref rid="B11" ref-type="bibr">11</xref>), it appears that these differences are at least partly associated with a diet rich in plant estrogens (phytoestrogens) in Asian countries (<xref rid="B11" ref-type="bibr">11</xref>).</p><p>Phytoestrogens are found naturally in many plants. They stick to estrogen receptors and perform different estrogenic and non-estrogenic activities (<xref rid="B5" ref-type="bibr">5</xref>). Soybeans are a rich source of phytoestrogens like isoflavones that includes genistein, daidzein and glycitein. Daily consumption in Asian countries is much higher than Western nations (1 to 36 g in Japan, Korea, Taiwan and Indonesia vs. 4 mg in United States) (<xref rid="B11" ref-type="bibr">11</xref>). In addition, there is evidence suggesting that the positive effect of soy products on vasomotor symptoms (<xref rid="B12" ref-type="bibr">12</xref>-<xref rid="B14" ref-type="bibr">14</xref>), maturation of vaginal epithelium (<xref rid="B15" ref-type="bibr">15</xref>), bone formation and resorption markers (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>), lipoproteins (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B18" ref-type="bibr">18</xref>), visual memory (<xref rid="B19" ref-type="bibr">19</xref>), nonverbal short-term memory, and frontal lobe function (<xref rid="B20" ref-type="bibr">20</xref>) at the age of menopause. However, there are studies negating the findings above. Hence the consumption of soy and its products as an alternative treatment to hormone therapy is discussed here. </p><p>Despite findings that suggest soy products have no impact on menopausal women's quality of life (<xref rid="B21" ref-type="bibr">21</xref>-<xref rid="B23" ref-type="bibr">23</xref>), there is some evidence indicating an improvement in the quality of life of menopausal women who consume soybeans (<xref rid="B11" ref-type="bibr">11</xref>) or its protein extracted (<xref rid="B24" ref-type="bibr">24</xref>). The study shows that the consumption of cow milk enriched with 50 mg of soy isoflavones can reduce vasomotor symptoms and improve quality of life among postmenopausal women (<xref rid="B16" ref-type="bibr">16</xref>).</p><p>Soy milk is a derivative of soybeans. Research into its effects on postmenopausal complications has been limited. Soy milk as a stable emulsion of oil, water and soy protein is made by soaking dried beans and grinding them with water. One of the advantages of these nutrients compared to other soybean products is that in addition to isoflavones, it has a composition similar to that of cow milk that can meet part of the individual&#x02019;s needed minerals such as calcium and iron (<xref rid="B25" ref-type="bibr">25</xref>).</p><p>This study aims to find out whether or not soy milk can act as a simple, affordable solution to middle-aged Iranian menopausal women by providing them with phytoestrogens and probably diminishing menopausal symptoms in them, and in turn improving the quality of their life.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><p>This study was performed as a randomized clinical trial among 264 postmenopausal women aged between 45 and 60 in the Vali-e-asr Reproductive Research Center, the Endocrine and Metabolism Research Center and the Women Research Centerat Alzahra University, Tehran, Iran, between 2009 and 2011. Before commencing the study, the survey was approved by the Ethics Committee of Tehran University of Medical Science and volunteers were informed verbally and in writing of the objectives of the study and how it would be conducted. </p><p>Of the 264 healthy postmenopausal asymptomatic women living in Tehran, Iran, who volunteered to participate in the study, eighty were selected. The written informed consent was obtained from all (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p><p>All the women underwent medical examination (interviews, hematology, biochemistry, gynecologic examination, Papanicolaou test, mammography, and transvaginal ultrasonography) in order to determine patient eligibility. </p><p>Inclusion criteria included a lapse of 1 to 7 years since the last menstruation and at least the daily occurrence of two vasomotor symptoms (hot Flashes and sweats). Those with FSH &#x0003c; 40 and Lack of menstruation &#x0003c; 12 months were excluded from the study. They were also asked if they had had treatment with hormone replacement therapy (HRT) (during the last 6 months), cholesterol-lowering, anti osteoporotic, or other interfering drugs (i.e. tibolone), if they had used any soy products (during the last 2 years), if they had diabetes or history of cancer, or if they were on a vegetarian diet. They were also examined for menopausal symptoms requiring therapy, and drug or nicotine addiction. The participants were also asked to say if they had a routine exercise program.</p><p>In brief, after the 80 recruited women completed the Beck Depression Inventory (BDI), they were randomized into following two groups: the Intervention group [40 women: 500 milliliter soy milk (MAXOY co, Iran) daily], and the Control Group (40 women: 500 milliliter low fat cow milk daily). Both groups also received daily calcium-D capsules (500 mg calcium and 200 IUD3, Pharma Drau., Iran). The patients had knowledge of the treatment assignment. Groups were obliged to record the daily number of hot flashes (the first week of study) and consumption of milk and capsules (during the8-month study) in a form.</p><p>The quality of life of the participants was examined on two occasions (at the baseline and the end of the eighth month). The interviewer used the standardized menopause-specific quality of life (MENQOL) questionnaire (<xref rid="B26" ref-type="bibr">26</xref>). The reliability and validity of this questionnaire has been approved previously by Iranian researchers in the translated version (<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>).</p><p>MENQOL is a 29-item questionnaire including four domains that evaluates the quality of life in postmenopausal women. The Domains include vasomotor (3 items), psychosocial (7 items), physical (16 items), and sexual (3 items). Each domain is scored separately. There is no overall score that can be obtained from this questionnaire since the relative contribution of each domain to an overall score is unknown.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Study flow chart illustrates enrollment, number of women in the intent-to-treat population, randomization to treatment groups, and follow-up of study participants</p></caption><graphic xlink:href="JFRH-9-93-g001"/><p>*MENQOL = Menopause Specific Quality of Life; MI = maturation index; FSH = Follicle Stimulating Hormone; E<sub>2 </sub>= Estradiol; Markers of bone turnover = Osteocalcin &#x00026;CTX-beta </p></fig><p>For all items, there is eight-point scale, ranging from one (no experience of problem) to eight (the most severe problem), suggesting higher scores indicate worse quality of life (<xref rid="B26" ref-type="bibr">26</xref>). The questionnaires were presented by a skilled person and the participants were requested to answer the questions carefully.</p><p>Throughout the study, Maxsoy Co. agreed to supply all the soy milk needed (the simple type). The type and quantity of isoflavones was measured by means of the HPLC system at the biomedical laboratory at Al-Zahra University&#x02019;s Center for Research on Women&#x02019;s Affairs. The concentrations of genistein and daidzein were determined as 28.86 mg per deciliter (&#x000b1; 66.0) and 8.25 milligrams per deciliter (&#x000b1; 13.1), respectively (<xref rid="B29" ref-type="bibr">29</xref>). In other words, each person consumed 500 ml of soy milk, about 185.55 mg of isoflavones (144.3 mg genistein and 41.25 mg daidzein) on a daily basis.</p><p>
<bold><italic>Statistical analysis</italic></bold>
</p><p>The data analysis was performed using version 17 of the SPSS (SPSS; SPSS Inc., Chicago, IL, USA) software. The mean and standard deviation (SD) scores were calculated for numerical variables, and the number and percentage for categorical variables. The p value &#x0003c; 0.05 was considered statistically significant. A confidence level of 95% and test power of 80% was considered. To examine whether the two groups were matched, the Chi-square test and nonparametric Mann-Whitney were used. In addition, a comparison was done of the two groups in terms of the effects of soy milk using the Mann-Whitney nonparametric test, and the change percent of domain score was then computed after intervention using the following formula: % change = [(post test score-pretest score) &#x000f7; pretest score] &#x000d7; 100.In each group, the Wilcoxon nonparametric test was used to compare the pretest and post-test.</p></sec><sec sec-type="results"><title>Results</title><p>In this study, of 264 volunteer postmenopausal women, 80 were eligible, of which 34 in the soy milk group (SG) and 23 in the control group (CG) completed the study (<xref ref-type="fig" rid="F1">Figure 1</xref>) and 23 participants were excluded for various reasons. The demographic data is shown in <xref ref-type="table" rid="T1">table 1</xref>. The two groups were matched for age, weight, height, body mass index (BMI), age at first menstruation (menarche), the duration of menopause, number of pregnancies, serum follicle-stimulating hormone (FSH) level, the test scores of depression (BDI) and the frequency of hot flashes per week In the SG, 50% were employed and64.7% had a high school diploma or higher education, while in the CG, 34.2% were employed and 47.8% had a high school diploma or higher degrees. But between the two groups in terms of occupation and education, there was no significant difference (p = 0.256 and p = 0.163, respectively, not reported in the table).</p><p>According to <xref ref-type="table" rid="T2">table 2</xref>, in both groups, after the intervention, the mean score of vasomotor domain decreased significantly (p = 0.011 in SG, p = 0.011 in CG). But the mean percentage change (<xref ref-type="table" rid="T3">Table 3</xref>), after comparing the two groups, were not significant statistically (-22.82 vs. -9.86 respectively, p = 0.501). The mean score of sexual domain no significantly decreased in SG (12.04 to 9.35, p = 0.058) and significant increased in the CG (6.85 to 9.54, p = 0.018). In contrast to the CG, the non-significant reduction was observed in the mean score of psychosocial and physical domains in SG. As mentioned previously, decreased score represents an improvement in quality of life and increased score indicates deterioration. Therefore an improvement was observed in the vasomotor domain in both groups and deterioration in the sexual domain in CG.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Comparison of demographic characteristics between the two groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th style="background-color:#4A6E62; color:#FFFFFF;" align="left" valign="middle" rowspan="1" colspan="1">Variables</th><th style="background-color:#4A6E62; color:#FFFFFF;" align="center" rowspan="1" colspan="1">Soy Milk group<break/>Mean (SD)</th><th style="background-color:#4A6E62; color:#FFFFFF;" align="center" rowspan="1" colspan="1">Control group<break/>Mean (SD)</th><th style="background-color:#4A6E62; color:#FFFFFF;" align="right" valign="middle" rowspan="1" colspan="1">p-value<xref ref-type="table-fn" rid="TFN1">*</xref></th></tr></thead><tbody><tr><td style=" color:#auto;" align="left" rowspan="1" colspan="1">
<bold>Age (year)</bold>
</td><td style=" color:#auto;" align="center" rowspan="1" colspan="1">
<bold>52.13 (3.05)</bold>
</td><td style=" color:#auto;" align="center" rowspan="1" colspan="1">
<bold>51.39 (2.89)</bold>
</td><td style=" color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.165</bold>
</td></tr><tr><td style="background-color:#E6EED5; color:#auto;" align="left" rowspan="1" colspan="1">
<bold>Weight (Kg)</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" rowspan="1" colspan="1">
<bold>68.55 (9.31)</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" rowspan="1" colspan="1">
<bold>68.07 (10.55)</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.827</bold>
</td></tr><tr><td style=" color:#auto;" align="left" rowspan="1" colspan="1">
<bold>Height (Cm)</bold>
</td><td style=" color:#auto;" align="center" rowspan="1" colspan="1">
<bold>154.69 (5.76)</bold>
</td><td style=" color:#auto;" align="center" rowspan="1" colspan="1">
<bold>154.68 (5.94)</bold>
</td><td style=" color:#auto;" align="center" rowspan="1" colspan="1">
<bold>0.987</bold>
</td></tr><tr><td style="background-color:#E6EED5; color:#auto;" align="left" rowspan="1" colspan="1">
<bold>BMI</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" rowspan="1" colspan="1">
<bold>28.68 (3.84)</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" rowspan="1" colspan="1">
<bold>28.64 (4.14)</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" rowspan="1" colspan="1">
<bold>0.873</bold>
</td></tr><tr><td style=" color:#auto;" align="left" rowspan="1" colspan="1">
<bold>Menarche (year)</bold>
</td><td style=" color:#auto;" align="center" rowspan="1" colspan="1">
<bold>13.5 (1.67)</bold>
</td><td style=" color:#auto;" align="center" rowspan="1" colspan="1">
<bold>13.64 (1.81)</bold>
</td><td style=" color:#auto;" align="center" rowspan="1" colspan="1">
<bold>0.909</bold>
</td></tr><tr><td style="background-color:#E6EED5; color:#auto;" align="left" rowspan="1" colspan="1">
<bold>Duration of menopause (year)</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" rowspan="1" colspan="1">
<bold>2.74 (1.6)</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" rowspan="1" colspan="1">
<bold>2.8 (1.72)</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" rowspan="1" colspan="1">
<bold>0.862</bold>
</td></tr><tr><td style=" color:#auto;" align="left" rowspan="1" colspan="1">
<bold>Gravida</bold>
</td><td style=" color:#auto;" align="center" rowspan="1" colspan="1">
<bold>3.47 (2.18)</bold>
</td><td style=" color:#auto;" align="center" rowspan="1" colspan="1">
<bold>4.0 (1.76)</bold>
</td><td style=" color:#auto;" align="center" rowspan="1" colspan="1">
<bold>0.556</bold>
</td></tr><tr><td style="background-color:#E6EED5; color:#auto;" align="left" rowspan="1" colspan="1">
<bold>FSH (mIu/ml)</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" rowspan="1" colspan="1">
<bold>81.97 (23.78)</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" rowspan="1" colspan="1">
<bold>81.67 (23.52)</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" rowspan="1" colspan="1">
<bold>0.981</bold>
</td></tr><tr><td style=" color:#auto;" align="left" rowspan="1" colspan="1">
<bold>BDI</bold>
</td><td style=" color:#auto;" align="center" rowspan="1" colspan="1">
<bold>10.13 (9.52)</bold>
</td><td style=" color:#auto;" align="center" rowspan="1" colspan="1">
<bold>14.21 (9.62)</bold>
</td><td style=" color:#auto;" align="center" rowspan="1" colspan="1">
<bold>0.135</bold>
</td></tr><tr><td style="background-color:#E6EED5; color:#auto;" align="left" rowspan="1" colspan="1">
<bold>Hot flashes (frequency per week)</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" rowspan="1" colspan="1">
<bold>26.06 (29.34)</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" rowspan="1" colspan="1">
<bold>24.6 (30.95)</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" rowspan="1" colspan="1">
<bold>0.664</bold>
</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>*</label><p>Mann-Whitney Test</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Comparison the pretest and post-test scores in each domain for two groups separately (Mean and Standard deviation)</p></caption><table frame="hsides" rules="groups"><thead><tr><th style="background-color:#4A6E62; color:#FFFFFF;" align="left" valign="middle" rowspan="3" colspan="1">Domains of quality of life</th><th style="background-color:#4A6E62; color:#FFFFFF;" align="center" valign="middle" colspan="6" rowspan="1">Group<hr/></th></tr><tr><th style="background-color:#4A6E62; color:#FFFFFF;" align="center" valign="middle" colspan="3" rowspan="1">Soy milk<hr/></th><th style="background-color:#4A6E62; color:#FFFFFF;" align="center" valign="middle" colspan="3" rowspan="1">Control<hr/></th></tr><tr><th style="background-color:#4A6E62; color:#FFFFFF;" align="center" valign="middle" rowspan="1" colspan="1">Before intervention</th><th style="background-color:#4A6E62; color:#FFFFFF;" align="center" valign="middle" rowspan="1" colspan="1">After intervention</th><th style="background-color:#4A6E62; color:#FFFFFF;" align="center" valign="middle" rowspan="1" colspan="1">p-value<xref ref-type="table-fn" rid="TFN2">*</xref></th><th style="background-color:#4A6E62; color:#FFFFFF;" align="center" valign="middle" rowspan="1" colspan="1">Before intervention</th><th style="background-color:#4A6E62; color:#FFFFFF;" align="center" valign="middle" rowspan="1" colspan="1">After intervention</th><th style="background-color:#4A6E62; color:#FFFFFF;" align="center" valign="middle" rowspan="1" colspan="1">p-value<xref ref-type="table-fn" rid="TFN2">*</xref></th></tr></thead><tbody><tr><td style=" color:#auto;" align="left" rowspan="1" colspan="1">
<bold>Vasomotor </bold>
<break/>
<bold>Mean (SD)</bold>
</td><td style=" color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">
<bold>13.36 (6.20)</bold>
</td><td style=" color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">
<bold>10.43 (6.34)</bold>
</td><td style=" color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.011</bold>
<xref ref-type="table-fn" rid="TFN3">&#x000a7;</xref>
</td><td style=" color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">
<bold>12.50(6.05)</bold>
</td><td style=" color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">
<bold>9.29 (5.47)</bold>
</td><td style=" color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.010&#x000a7;</bold>
</td></tr><tr><td style="background-color:#E6EED5; color:#auto;" align="left" rowspan="1" colspan="1">
<bold>Psychosocial </bold>
<break/>
<bold>Mean (SD)</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">
<bold>21.68 (12.53</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">
<bold>18.52 (10.03)</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.398</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">
<bold>20.58 (8.05)</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">
<bold>22.33 (5.23</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.432</bold>
</td></tr><tr><td style=" color:#auto;" align="left" rowspan="1" colspan="1">
<bold>Physical</bold>
<break/>
<bold>Mean (SD)</bold>
</td><td style=" color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">
<bold>54.67 (27.74)</bold>
</td><td style=" color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">
<bold>53.83 (21.04)</bold>
</td><td style=" color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.831</bold>
</td><td style=" color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">
<bold>45.73 (12.43)</bold>
</td><td style=" color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">
<bold>52.27 (11.0)</bold>
</td><td style=" color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.172</bold>
</td></tr><tr><td style="background-color:#E6EED5; color:#auto;" align="left" rowspan="1" colspan="1">
<bold>Sexual</bold>
<break/>
<bold>Mean (SD)</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">
<bold>12.04 (7.80)</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">
<bold>9.35 (5.73)</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.058</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">
<bold>6.85 (3.58)</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">
<bold>9.54 (6.64)</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.018</bold>
<xref ref-type="table-fn" rid="TFN3">&#x000a7;</xref>
</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><label>*</label><p>Wilcoxon Test; </p></fn><fn id="TFN3"><label>&#x000a7;</label><p> Significant &#x0003c; 0.05</p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Comparison of the percentage change in each domain score between the two groups after intervention</p></caption><table frame="hsides" rules="groups"><thead><tr><th style="background-color:#4A6E62; color:#FFFFFF;" align="left" valign="middle" rowspan="2" colspan="1">Domains of quality of life</th><th style="background-color:#4A6E62; color:#FFFFFF;" align="center" colspan="2" rowspan="1">Mean of % change<hr/></th><th style="background-color:#4A6E62; color:#FFFFFF;" align="center" valign="middle" rowspan="2" colspan="1">p-value<xref ref-type="table-fn" rid="TFN4">*</xref></th></tr><tr><th style="background-color:#4A6E62; color:#FFFFFF;" align="center" rowspan="1" colspan="1">Soy milk</th><th style="background-color:#4A6E62; color:#FFFFFF;" align="center" rowspan="1" colspan="1">Control</th></tr></thead><tbody><tr><td style=" color:#auto;" align="left" rowspan="1" colspan="1">
<bold>Vasomotor </bold>
</td><td style=" color:#auto;" align="center" rowspan="1" colspan="1">
<bold>-9.86</bold>
</td><td style=" color:#auto;" align="center" rowspan="1" colspan="1">
<bold>-22.82</bold>
</td><td style=" color:#auto;" align="center" rowspan="1" colspan="1">
<bold>0.501</bold>
</td></tr><tr><td style="background-color:#E6EED5; color:#auto;" align="left" rowspan="1" colspan="1">
<bold>Psychosocial </bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" rowspan="1" colspan="1">
<bold>-1.15</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" rowspan="1" colspan="1">
<bold>27.68</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" rowspan="1" colspan="1">
<bold>0.296</bold>
</td></tr><tr><td style=" color:#auto;" align="left" rowspan="1" colspan="1">
<bold>Physical </bold>
</td><td style=" color:#auto;" align="center" rowspan="1" colspan="1">
<bold>7.77</bold>
</td><td style=" color:#auto;" align="center" rowspan="1" colspan="1">
<bold>22.03</bold>
</td><td style=" color:#auto;" align="center" rowspan="1" colspan="1">
<bold>0.550</bold>
</td></tr><tr><td style="background-color:#E6EED5; color:#auto;" align="left" rowspan="1" colspan="1">
<bold>Sexual</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" rowspan="1" colspan="1">
<bold>0.46</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" rowspan="1" colspan="1">
<bold>33.94</bold>
</td><td style="background-color:#E6EED5; color:#auto;" align="center" rowspan="1" colspan="1">
<bold>0.031</bold>
<xref ref-type="table-fn" rid="TFN5">&#x000a7;</xref>
</td></tr></tbody></table><table-wrap-foot><fn id="TFN4"><label>*</label><p>Mann-Whitney Test; </p></fn><fn id="TFN5"><label>&#x000a7;</label><p> Significant &#x0003c; 0.05</p></fn></table-wrap-foot></table-wrap><p>The mean percentage change of the vasomotor domain score (<xref ref-type="table" rid="T3">Table 3</xref>), after comparing the two groups, were not significant statistically (-9.86 in SG, -22.82 in CG, p = 0.501). Also in the CG compared with SG, the mean percentage changes in the other domains scores (psychosocial, physical and sexual) increased as well as the mean scores. However, comparing the two groups, the difference of the mean percentage change in the sexual domain score is only significant (0.46 in SG, 33.94 in CG, p = 0.031).</p></sec><sec sec-type="discussion"><title>Discussion</title><p>In early menopause, vasomotor symptoms such as hot flashes and night sweats; somatic symptoms such as fatigue, physical pain, and vaginal dryness; and psychological symptoms such as irritability, anxiety, depression, decreased libido and difficulty sleeping are often reported. The number and duration of vasomotor symptoms vary among different populations. The average length of flashing is six months to five years; however, in 20% of the cases, they may continue until the age 70 or 80 (<xref rid="B30" ref-type="bibr">30</xref>).Williams et al. have done a study on2,703 American postmenopausal women between the ages of 40 and 65. Results showed that hot Flashes affects work (46.0%), social activities (44.4%), leisure activities (47.6%), sleep (82.0%), mood (68.6%), concentration (69.0%), sexual activity (40.9%), and total energy level (63.3%),hence decreases the overall quality of life by as much as 69.3% (<xref rid="B31" ref-type="bibr">31</xref>).</p><p>The probability of this risk in women with severe hot flashes is 3.58 against women with low to moderate hot flashes. Therefore, effective and safe treatment that reduces the symptoms can improve the quality of life (<xref rid="B31" ref-type="bibr">31</xref>).</p><p>Studies show that vasomotor symptoms are clearly associated with lower estrogen levels. Thus estrogen therapy in postmenopausal women significantly improves hot flashes and sweating. The results of studies on the effects of soy products on menopausal symptoms and the quality of life in postmenopausal women are very different. The reason for this difference is mostly because of the non-uniform conditions such as differences in age range of the subjects and duration of the menopausal age, the number and severity of hot flashes, sample size, duration of intervention, and different products of soy isoflavones consumed. In addition, the studies conducted to assess menopausal symptoms have generally observed a significant placebo effect in reducing hot flashes (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B13" ref-type="bibr">13</xref>).</p><p>Also, the metabolism of isoflavones depends on intestinal flora and the dietary intake of antibiotics. Yet there are individual differences. Only a third of people have the ability to produce equol (the most potent metabolite of soy derived from daidzein) (<xref rid="B32" ref-type="bibr">32</xref>). The amount of isoflavones in soy food products differs, depending on the type of soybeans, harvest year and geographic locations (<xref rid="B33" ref-type="bibr">33</xref>). Therefore, such studies are faced with limitations and their results should be compared while keeping the afore-mentioned restrictions in mind.</p><p>Apart from this study, there have been at least seven other studies that evaluated the quality of life in postmenopausal women who consume soy milk (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B20" ref-type="bibr">20</xref>-<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B34" ref-type="bibr">34</xref>). In the three studies, this association was significant, but non-significant in other four studies. It appears that differences in products used to intervene are the main factor leading to the differences in results. However, in some cases, even with the use of the same product, different results can be observed.</p><p>In the study conducted by Garc&#x000ed;a-Mart&#x000ed;n, milk enriched with isoflavones extracted from soy was used (<xref rid="B23" ref-type="bibr">23</xref>), whereas in the studies done by Amato (<xref rid="B20" ref-type="bibr">20</xref>) and Ho (<xref rid="B21" ref-type="bibr">21</xref>), only isoflavones extracted were utilized. However, in the Garc&#x000ed;a-Mart&#x000ed;n&#x02019;s study, the quality of life improved, and in the other two, it didn&#x02019;t make a difference. Soy protein was studied with different values in the studies of Basaria (<xref rid="B24" ref-type="bibr">24</xref>), Welty (<xref rid="B11" ref-type="bibr">11</xref>) and Kok (<xref rid="B23" ref-type="bibr">23</xref>). In the studies by Basaria (<xref rid="B24" ref-type="bibr">24</xref>) and Welty (<xref rid="B11" ref-type="bibr">11</xref>), soy protein was successful, whereas in the study by Kok (<xref rid="B23" ref-type="bibr">23</xref>), it failed to improve the quality of life. Also, soy flour was used in the Lewis&#x02019;s study, but no difference was found between groups in terms of hot flashes and the quality of life (<xref rid="B34" ref-type="bibr">34</xref>).</p><p>In present study, differences in the quality of life in postmenopausal women consuming soy milk and the control group were not significant. However, in each group, significant improvement in vasomotor domain was reported. Still there was no difference between them, which does not indicate little or no effect of soy milk on the vasomotor domain. But it seems that it may indicate a need to increase the duration of the study to establish the effects of soy milk and to have proper selection of samples, in terms of the number and severity of hot flashes. There is evidence indicating a significant reduction in hot flashes in the control group (even to the extent of 50%) (<xref rid="B5" ref-type="bibr">5</xref>) And greater effectiveness of soy and its products in women with more severe vasomotor symptoms (<xref rid="B11" ref-type="bibr">11</xref>).</p><p>However, this study showed significant but weak effect of soy milk on the sexual domain as well as non-significant improvement in the Psychosocial and physical aspects were found. While in the control group, in the rest of the domains except the vasomotor, there was a non-significant reduction in the quality of life. It is recommended that further study to be done with a larger sample size, more prolonged, and with participants who have severer vasomotor symptoms. </p></sec></body><back><ack><title>Acknowledgments</title><p>This study was done in the frame of a research project supported by the Tehran University of Medical Sciences, Tehran, Iran. We would like to thank the research deputy and also all our colleagues at the Gynecological Department of Vali-e-Asr Hospital and Research Center.</p></ack><ref-list><title>References</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saigal</surname><given-names>S</given-names></name><name><surname>Tyson</surname><given-names>J</given-names></name></person-group><article-title>Measurement of Quality of Life of Survivors of Neonatal Intensive Care: Critique and Implications</article-title><source> Semin Perinatol </source><year>2008</year><volume>32</volume><fpage>59</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">18249241</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayers</surname><given-names>B</given-names></name><name><surname>Hunter</surname><given-names>MS</given-names></name></person-group><article-title>Health-related quality of life of women with menopausal hot flushes and night sweats</article-title><source>Climacteric</source><year>2013</year><volume>16</volume><fpage>235</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">22809134</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenblum</surname><given-names>CA</given-names></name><name><surname>Rowe</surname><given-names>MA</given-names></name><name><surname>Neff</surname><given-names>DF</given-names></name><name><surname>Greenblum</surname><given-names>JS</given-names></name></person-group><article-title>Midlife women: symptoms associated with menopausal transition and early postmenopause and quality of life</article-title><source> Menopause.Menopause</source><year>2013</year><volume>20</volume><fpage>22</fpage><lpage>7</lpage></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>G</given-names></name><name><surname>Kuh</surname><given-names>D</given-names></name></person-group><article-title>Perceived change in quality of life during the menopause</article-title><source> Soc Sci Med</source><year>2006</year><volume>62</volume><fpage>93</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">15990213</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Speroff</surname><given-names>L</given-names></name><name><surname>Fritz</surname><given-names>MA</given-names></name></person-group><source>Clinical Gynecologic Endocrinology and Infertility</source><year>2005</year><edition>7th Edition</edition><publisher-name>Lippincott williams &#x00026; wilkings</publisher-name></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gambacciani</surname><given-names>M</given-names></name></person-group><article-title>New HRT options for the treatment of menopausal symptoms and the maintenance of quality of life in postmenopausal women</article-title><source> Endocrine</source><year>2004</year><volume>24</volume><fpage>231</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15542890</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitkin</surname><given-names>J</given-names></name><name><surname>Smetnik</surname><given-names>VP</given-names></name><name><surname>Vad&#x000e1;sz</surname><given-names>P</given-names></name><name><surname>Mustonen</surname><given-names>M</given-names></name><name><surname>Salminen</surname><given-names>K</given-names></name><name><surname>Ylikangas</surname><given-names>S</given-names></name></person-group><article-title>Continuous combined hormone replacement therapy relieves climacteric symptoms and improves health-related quality of life in early postmenopausal women</article-title><source> Menopause Int</source><year>2007</year><volume>13</volume><fpage>116</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">17785037</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>YF</given-names></name><name><surname>Sun</surname><given-names>ZQ</given-names></name></person-group><article-title>Quality of life in the treatment assessment of postmenopausal osteoporosis</article-title><source> Zhong Nan Da Xue Xue Bao Yi Xue Ban</source><year>2005</year><volume>30</volume><fpage>299</fpage><lpage>303</lpage><pub-id pub-id-type="pmid">16045018</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welton</surname><given-names>AJ</given-names></name><name><surname>Vickers</surname><given-names>MR</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Ford</surname><given-names>D</given-names></name><name><surname>Lawton</surname><given-names>BA</given-names></name><name><surname>MacLennan</surname><given-names>AH</given-names></name><etal/></person-group><article-title>Health related quality of life after combined hormone replacement therapy: randomised controlled trial</article-title><source> BMJ</source><year>2008</year><volume>337</volume><fpage>1190</fpage></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossouw</surname><given-names>JE</given-names></name><name><surname>Anderson</surname><given-names>GL</given-names></name><name><surname>Prentice</surname><given-names>RL</given-names></name><name><surname>LaCroix</surname><given-names>AZ</given-names></name><name><surname>Kooperberg</surname><given-names>C</given-names></name><name><surname>Stefanick</surname><given-names>ML</given-names></name><etal/></person-group><article-title>Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial</article-title><source> JAMA</source><year>2002</year><day>17</day><volume>288</volume><fpage>321</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">12117397</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welty</surname><given-names>FK</given-names></name><name><surname>Lee</surname><given-names>KS</given-names></name><name><surname>Lew</surname><given-names>NS</given-names></name><name><surname>Nasca</surname><given-names>M</given-names></name><name><surname>Zhou</surname><given-names>JR</given-names></name></person-group><article-title>The association between soy nut consumption and decreased menopausal symptoms</article-title><source> J Womens Health (Larchmt)</source><year>2007</year><volume>16</volume><fpage>361</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17439381</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>YB</given-names></name><name><surname>Wang</surname><given-names>ZL</given-names></name><name><surname>Zhuo</surname><given-names>SY</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Liao</surname><given-names>HF</given-names></name><name><surname>Verbruggen</surname><given-names>M</given-names></name><etal/></person-group><article-title>Soy germ isoflavones improve menopausal symptoms but have no effect on blood lipids in early postmenopausal Chinese women: a randomized placebo-controlled trial</article-title><source> Menopause</source><year>2012</year><volume>19</volume><fpage>791</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">22278344</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nahas</surname><given-names>EA</given-names></name><name><surname>Nahas-Neto</surname><given-names>J</given-names></name><name><surname>Orsatti</surname><given-names>FL</given-names></name><name><surname>Carvalho</surname><given-names>EP</given-names></name><name><surname>Oliveira</surname><given-names>ML</given-names></name><name><surname>Dias</surname><given-names>R</given-names></name></person-group><article-title>Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized, double-blind, and placebo-controlled study</article-title><source> Maturitas</source><year>2007</year><volume>58</volume><fpage>249</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">17913408</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>TS</given-names></name><name><surname>Wang</surname><given-names>SY</given-names></name><name><surname>Yang</surname><given-names>YC</given-names></name><name><surname>Su</surname><given-names>CH</given-names></name><name><surname>Lee</surname><given-names>FK</given-names></name><name><surname>Chen</surname><given-names>SC</given-names></name><etal/></person-group><article-title>Effects of standardized phytoestrogen on Taiwanese menopausal women</article-title><source> Taiwan J Obstet Gynecol</source><year>2012</year><volume>51</volume><fpage>229</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">22795099</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiechi</surname><given-names>LM</given-names></name><name><surname>Putignano</surname><given-names>G</given-names></name><name><surname>Guerra</surname><given-names>V</given-names></name><name><surname>Schiavelli</surname><given-names>MP</given-names></name><name><surname>Cisternino</surname><given-names>AM</given-names></name><name><surname>Carriero</surname><given-names>C</given-names></name></person-group><article-title>The effect of a soy rich diet on the vaginal epithelium in postmenopause: a randomized double blind trial</article-title><source> Maturitas</source><year>2003</year><volume>45</volume><fpage>241</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">12927310</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-Mart&#x000ed;n</surname><given-names>A</given-names></name><name><surname>Quesada</surname><given-names>Charneco M</given-names></name><name><surname>Alv&#x000e1;rez</surname><given-names>Guisado A</given-names></name><name><surname>Jim&#x000e9;nez</surname><given-names>Mole&#x000f3;n JJ</given-names></name><name><surname>Fonoll&#x000e1;</surname><given-names>Joya J</given-names></name><name><surname>Mu&#x000f1;oz-Torres</surname><given-names>M</given-names></name></person-group><article-title>[Effect of milk product with soy isoflavones on quality of life and bone metabolism in postmenopausal Spanish women: randomized trial]</article-title><source> Med Clin (Barc) </source><year>2012</year><volume>138</volume><fpage>47</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">22024564</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atkinson</surname><given-names>C</given-names></name><name><surname>Day</surname><given-names>NE</given-names></name><name><surname>Dowsett</surname><given-names>M</given-names></name><name><surname>Bingham</surname><given-names>SA</given-names></name></person-group><article-title>Compston JE</article-title><source> The effects of phytoestrogen isoflavones on bone desity in women: a double- blind, randomized, placebo- controlled trial. Am J Clin Nutr</source><year>2004</year><volume>79</volume><fpage>326</fpage><lpage>33</lpage></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petri</surname><given-names>Nahas E</given-names></name><name><surname>Nah&#x000e1;s</surname><given-names>Neto J</given-names></name><name><surname>De</surname><given-names>Luca L</given-names></name><name><surname>Traiman</surname><given-names>P</given-names></name><name><surname>Pontes</surname><given-names>A</given-names></name><name><surname>Dalben</surname><given-names>I</given-names></name></person-group><article-title>Benefits of soy germ isoflavones in postmenopausal women with contraindication for conventional hormone replacement therapy</article-title><source> Maturitas</source><year>2004</year><volume>48</volume><fpage>372</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">15283929</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henderson</surname><given-names>VW</given-names></name><name><surname>St</surname><given-names>John JA</given-names></name><name><surname>Hodis</surname><given-names>HN</given-names></name><name><surname>Kono</surname><given-names>N</given-names></name><name><surname>McCleary</surname><given-names>CA</given-names></name><name><surname>Franke</surname><given-names>AA</given-names></name><etal/></person-group><article-title>Long-term soy isoflavone supplementation and cognition in women: a randomized, controlled trial</article-title><source> Neurology</source><year>2012</year><volume>78</volume><fpage>1841</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">22665144</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>File</surname><given-names>SE</given-names></name><name><surname>Hartley</surname><given-names>DE</given-names></name><name><surname>Elsabagh</surname><given-names>S</given-names></name><name><surname>Duffy</surname><given-names>R</given-names></name><name><surname>Wiseman</surname><given-names>H</given-names></name></person-group><article-title>Cognitive improvement after 6 week of soy supplements in postmenoposal women is limited to frontal bone function</article-title><source>Menopause</source><year>2005</year><volume>12</volume><fpage>193</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">15772567</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amato</surname><given-names>P</given-names></name><name><surname>Young</surname><given-names>RL</given-names></name><name><surname>Steinberg</surname><given-names>FM</given-names></name><name><surname>Murray</surname><given-names>MJ</given-names></name><name><surname>Lewis</surname><given-names>RD</given-names></name><name><surname>Cramer</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Effect of soy isoflavone supplementation on menopausal quality of life</article-title><source> Menopause</source><year>2013</year><fpage>20443</fpage><lpage>7</lpage></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>SC</given-names></name><name><surname>Chan</surname><given-names>AS</given-names></name><name><surname>Ho</surname><given-names>YP</given-names></name><name><surname>So</surname><given-names>EK</given-names></name><name><surname>Sham</surname><given-names>A</given-names></name><name><surname>Zee</surname><given-names>B</given-names></name><etal/></person-group><article-title>Effects of soy isoflavone supplementation on cognitive function in Chinese postmenopausal women: a double-blind, randomized, controlled trial</article-title><source> Menopause</source><year>2007</year><volume>14</volume><fpage>489</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">17308499</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kok</surname><given-names>L</given-names></name><name><surname>Kreijkamp-Kaspers</surname><given-names>S</given-names></name><name><surname>Grobbee</surname><given-names>DE</given-names></name><name><surname>Lampe</surname><given-names>JW</given-names></name><name><surname>van</surname><given-names>der Schouw YT</given-names></name></person-group><article-title>A randomized, placebo-controlled trial on the effects of soy protein containing isoflavones on quality of life in postmenopausal women</article-title><source> Menopause</source><year>2005</year><volume>12</volume><fpage>56</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">15668601</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basaria</surname><given-names>S</given-names></name><name><surname>Wisniewski</surname><given-names>A</given-names></name><name><surname>Dupree</surname><given-names>K</given-names></name><name><surname>Bruno</surname><given-names>T</given-names></name><name><surname>Song</surname><given-names>MY</given-names></name><name><surname>Yao</surname><given-names>F</given-names></name><etal/></person-group><article-title>Effect of high-dose isoflavones on cognition, quality of life, androgens, and lipoprotein in post-menopausal women</article-title><source> J Endocrinol Invest</source><year>2009</year><volume>32</volume><fpage>150</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">19411814</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassanzadeh</surname><given-names>A</given-names></name></person-group><article-title>Soy milk and its properties</article-title><source>Science of Food and Agriculture</source><year>2010</year><volume>84</volume><comment>[In Persian]</comment></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hilditch</surname><given-names>JR</given-names></name><name><surname>Lewis</surname><given-names>J</given-names></name><name><surname>Peter</surname><given-names>A</given-names></name><name><surname>van</surname><given-names>Maris B</given-names></name><name><surname>Ross</surname><given-names>A</given-names></name><name><surname>Franssen</surname><given-names>E</given-names></name><etal/></person-group><article-title>A menopause-specific quality of life questionnaire: development and psychometric properties</article-title><source> Maturitas</source><year>1996</year><volume>24</volume><fpage>161</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">8844630</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shabani</surname><given-names>B</given-names></name><name><surname>Nazem</surname><given-names>Gh</given-names></name><name><surname>Pooraghaie</surname><given-names>F</given-names></name><name><surname>Ardakani</surname><given-names>Z</given-names></name></person-group><article-title>Effects of training on quality of life in postmenopausal women with non-athletes</article-title><source> Research in Sports Sciences</source><year>2007</year><volume>12</volume><fpage>123</fpage><lpage>33</lpage><comment>[In Persian]</comment></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golyan</surname><given-names>Tehrani Sh</given-names></name><name><surname>Mir</surname><given-names>Mohammad A</given-names></name><name><surname>Mahmoudi</surname><given-names>M</given-names></name><name><surname>Khaledian</surname><given-names>Z</given-names></name></person-group><article-title>Study of quality of life and its patterns in different stages of menopause for women in Tehran</article-title><source> Hayat</source><year>2002</year><volume>8</volume><fpage>33</fpage><lpage>41</lpage><comment>[In Persian]</comment></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golkhoo</surname><given-names/></name><name><surname>Ahmadi</surname><given-names>AR</given-names></name><name><surname>Hanachi</surname><given-names>P</given-names></name><name><surname>Barantalab</surname><given-names>F</given-names></name><name><surname>Vaziri</surname><given-names>M</given-names></name></person-group><article-title>Determination of Daidzein and Genistein in Soy Milk in Iran by Using HPLC Analysis Method</article-title><source> Pakistan Journal of Biological Science</source><year>2008</year><volume>11</volume><fpage>2254</fpage><lpage>58</lpage></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levis</surname><given-names>S</given-names></name><name><surname>Griebeler</surname><given-names>ML</given-names></name></person-group><article-title>The Role of Soy Foods in the Treatment of Menopausal Symptoms</article-title><source> J Nutr</source><year>2010</year><volume>140</volume><fpage>2318S</fpage><lpage>21S</lpage><pub-id pub-id-type="pmid">21047930</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>RE</given-names></name><name><surname>Levineb</surname><given-names>KB</given-names></name><name><surname>Kalilani</surname><given-names>L</given-names></name><name><surname>Lewisc</surname><given-names>J</given-names></name><name><surname>Clark</surname><given-names>RV</given-names></name></person-group><article-title>Menopause-specific questionnaire assessment in US population-based study shows negative impact on health-related quality of life</article-title><source> Maturitas</source><year>2009</year><volume>62</volume><fpage>153</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">19157732</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levis</surname><given-names>S</given-names></name><name><surname>Strickman-Stein</surname><given-names>N</given-names></name><name><surname>Daniel</surname><given-names>R</given-names></name><name><surname>Doerge</surname><given-names>DR</given-names></name><name><surname>Krischer</surname><given-names>J</given-names></name></person-group><article-title>Design and baseline characteristics of The Soy Phytoestrogens As Replacement Estrogen (SPARE) Study - A clinical trial of the effects of soy isoflavones in menopausal women</article-title><source> Contemp Clin Trials</source><year>2010</year><volume>31</volume><fpage>293</fpage><lpage>302</lpage><pub-id pub-id-type="pmid">20230914</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sa'eed</surname><given-names>Bawa</given-names></name></person-group><article-title>The Significance of Soy Protein and Soy Bioactive Compounds in the Prophylaxis and Treatment of Osteoporosis</article-title><source> J Osteoporos</source><year>2010</year><volume>2010</volume><fpage>891058</fpage><pub-id pub-id-type="pmid">20981338</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>JE</given-names></name><name><surname>Nickell</surname><given-names>LA</given-names></name><name><surname>Thompson</surname><given-names>LU</given-names></name><name><surname>Szalai</surname><given-names>JP</given-names></name><name><surname>Kiss</surname><given-names>A</given-names></name><name><surname>Hilditch</surname><given-names>JR</given-names></name></person-group><article-title>A randomized controlled trial of the effect of dietary soy and flaxseed muffins on quality of life and hot flashes during menopause</article-title><source> Menopause</source><year>2006</year><volume>13</volume><fpage>631</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">16837885</pub-id></element-citation></ref></ref-list></back></article>